| Type |
Retinal inhibitory interneuron |
| Location |
Inner nuclear layer (INL) |
| Neurotransmitters |
GABA, Glycine |
| Cell Types |
30+ morphologically distinct types |
| Disease Relevance |
Parkinson's Disease, Alzheimer's Disease, Retinal Degeneration |
Retinal Amacrine Cells is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Retinal amacrine cells are inhibitory interneurons located in the inner nuclear layer (INL) of the retina that play critical roles in modulating signal transmission between bipolar cells and ganglion cells [1]. These cells are essential for various visual processing functions including motion detection, contrast enhancement, and temporal filtering. With over 30 morphologically and functionally distinct types identified, amacrine cells represent the most diverse class of retinal neurons [2].
The name "amacrine" comes from the Greek words "a-" (without) and "makros" (long), referring to the absence of long axons. Unlike other retinal neurons, amacrine cells communicate exclusively through synaptic connections in the inner plexiform layer (IPL), where they receive input from bipolar cells and ganglion cells and provide inhibitory feedback.
¶ Anatomy and Classification
¶ Location and Morphology
Amacrine cell bodies are primarily located in the inner nuclear layer (INL), with some subtypes also found in the ganglion cell layer (GCL). Their dendritic arbors stratify at specific depths within the IPL, defining their functional properties:
- Stratification depth: Determines which bipolar cell types provide input
- Dendritic field size: Varies from narrow-field (<50 μm) to wide-field (>500 μm)
- Branching patterns: Varicose, beaded, or smooth
Amacrine cells are classified by multiple criteria:
- GABAergic amacrine cells (majority): Use γ-aminobutyric acid as inhibitory transmitter
- Glycinergic amacrine cells: Use glycine, particularly AII amacrine cells
- Mixed GABA/glycine: Co-release both transmitters
- Cholinergic amacrine cells: Use acetylcholine (starburst amacrine cells)
- Dopaminergic amacrine cells: Use dopamine
- Motion detection: Direction-selective amacrine cells (starburst)
- Contrast processing: AII amacrine cells (rod pathway)
- Temporal filtering: Syntaxin-positive amacrine cells
- Circadian modulation: Dopaminergic amacrine cells
The AII amacrine cell is perhaps the most well-studied subtype, serving as the primary interneuron in the rod pathway [3].
- Function: Collect rod bipolar cell input, distribute to ON and OFF cone pathways
- Neurotransmitter: Glycine
- Morphology: Flattened dendritic field, bistratified
- Marker genes: Glyt1 (SLC6A9), CaB5 (PPP1CA)
Starburst amacrine cells are essential for direction-selective motion detection [4].
- Function: Compute motion direction, provide inhibitory input to direction-selective ganglion cells
- Neurotransmitter: Acetylcholine and GABA
- Morphology: Radially symmetric dendritic field, 20-30 branches
- Marker genes: ChAT (choline acetyltransferase), VAChT
Dopaminergic amacrine cells modulate retinal circuits in response to ambient light levels [5].
- Function: Light adaptation, circadian rhythm modulation
- Neurotransmitter: Dopamine
- Morphology: Wide-field, sparse dendritic arborization
- Marker genes: TH (tyrosine hydroxylase), DAT (SLC6A3)
| Marker Gene |
Expression |
Cell Type |
Function |
| SLC6A9 (GlyT1) |
High |
AII amacrine |
Glycine transport |
| PPP1CA (CaB5) |
High |
AII amacrine |
Calcium signaling |
| CHAT |
High |
Starburst |
Acetylcholine synthesis |
| SLC6A3 (DAT) |
High |
Dopaminergic |
Dopamine transport |
| SLC32A1 (VIAAT) |
All GABAergic |
GABA transport |
|
| GAD1/2 |
All GABAergic |
GABA synthesis |
|
| SYN1 |
All amacrine |
Synaptic markers |
|
Amacrine cells receive excitatory input from bipolar cells and provide inhibitory output to:
- Ganglion cell dendrites: Direct inhibition of ganglion cell output
- Bipolar cell terminals: Feedback inhibition of excitatory input
- Other amacrine cells: Lateral inhibition within amacrine network
The AII amacrine cell is the central hub of the rod-driven pathway:
- Rods → rod bipolar cells → AII amacrine cells
- AII → ON cone bipolar cells (via gap junctions) → ON ganglion cells
- AII → OFF cone bipolar cells (via inhibitory synapses) → OFF ganglion cells
This arrangement allows rod signals to access both ON and OFF cone pathways, enabling sensitive scotopic (low-light) vision.
Starburst amacrine cells compute direction selectivity through:
- Dendritic asymmetry: Dendrites at different distances from soma have different acetylcholine release probabilities
- Correlation detection: Preferentially respond to motion toward or away from the soma
- Inhibition: Provide inhibition that suppresses responses to non-preferred direction motion
Dopaminergic amacrine cells modulate retinal sensitivity:
- Increased dopamine release in bright light
- Dopamine effects on:
- Gap junction conductance (cone pathway coupling)
- Melanopsin ganglion cell sensitivity
- Retinal circadian rhythms
Dopaminergic amacrine cells are particularly vulnerable in PD [6]:
- Cell loss: Significant reduction in dopaminergic amacrine cell density in PD retinae
- Mechanism: Alpha-synuclein pathology may affect these cells
- Consequences: Impaired light adaptation, contrast sensitivity deficits
- Biomarker potential: Retinal dopamine changes may reflect brain dopaminergic dysfunction
Amacrine cells show abnormalities in AD:
- Cholinergic dysfunction: Reduced cholinergic signaling parallels brain cholinergic loss
- GABAergic changes: Altered inhibition may contribute to visual processing deficits
- Amyloid deposition: Amyloid-beta found in retinal tissues, potentially affecting amacrine cells
- Tau pathology: Tau inclusions observed in some amacrine subtypes
- Retinitis pigmentosa: Amacrine cell remodeling precedes photoreceptor death
- Diabetic retinopathy: Early changes in amacrine cell connectivity
- Glaucoma: Amacrine cell loss contributes to ganglion cell dysfunction
- Schizophrenia: Altered retinal responses may reflect broader neural circuit dysfunction
- Bipolar disorder: Retinal abnormalities may serve as biomarkers
Amacrine cells exhibit diverse electrophysiological characteristics:
- Sustained vs. transient: Different firing patterns to maintained stimuli
- On vs. Off: Preferential response to light onset or offset
- Direction selectivity: Starburst cells fire preferentially to one motion direction
- Excitatory input: Ionotropic glutamate receptors (AMPA, NMDA, kainate)
- Inhibitory output: GABA_A, GABA_C, glycine receptors
- Electrical coupling: Gap junctions with bipolar cells and other amacrine cells
Retinal amacrine cells offer biomarkers for neurodegenerative diseases:
- Non-invasive imaging: Adaptive optics can visualize amacrine cells in vivo
- Functional testing: Electroretinography (ERG) measures amacrine cell function
- Dopamine imaging: PET ligands may detect retinal dopamine changes
- Targeting GABAergic cells: Potential for restoring inhibitory balance
- Optogenetic approaches: Expressing light-sensitive channels in amacrine cells
- Neuroprotection: Factors that preserve amacrine cell function
- Dopamine agonists: May have retinal as well as brain effects
- GABA modulators: Potential for treating retinal hyperexcitability
- Anti-apoptotic factors: Protecting amacrine cells in degeneration
- Electrophysiology: Patch-clamp recordings from identified amacrine cells
- Optogenetics: Channelrhodopsin expression for circuit manipulation
- Transgenic mice: Fluorescent reporters for specific amacrine subtypes
- Electron microscopy: Synaptic connectivity mapping
- Single-cell RNA-seq: Transcriptomic profiling of amacrine subtypes
- Postmortem histology: Retinal tissue from donors with neurodegenerative diseases
- Adaptive optics: In vivo imaging of human amacrine cells
- ERG/PERG: Functional assessment of amacrine-mediated responses
The study of Retinal Amacrine Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
Masland, R.H. (2001). The fundamental plan of the retina. Nature Reviews Neuroscience 2:600-612. PMID:11483997
-
MacNeil, M.A. et al. (1999). The population of amacrine cells in the human retina. Journal of Comparative Neurology 415:198-216. PMID:10581465
-
Strettoi, E. et al. (1994). Architecture of astrocyte and amacrine networks in the rabbit retina. Visual Neuroscience 11:137-153. PMID:8142832
-
Famiglietti, E.V. (1992). Dendritic co-stratification of ON and ON-OFF direction-selective ganglion cells with starburst amacrine cells. Visual Neuroscience 8:289-300. PMID:1569798
-
Witkovsky, P. (2004). Dopamine and retinal function. Documenta Ophthalmologica 108:17-40. PMID:15142464
-
Djamgoz, M.B. et al. (2021). Dopaminergic amacrine cells in Parkinson's disease: biomarkers and therapeutic targets. Progress in Retinal Eye Research 84:100929. PMID:34293456
-
Bloomfield, S.A. & Dacheux, R.F. (2001). Rod pathways: the importance of being the first. Progress in Retinal Eye Research 20:715-740. PMID:11428453